BioSpace News Archive

Bio NC

Monarch Medical Technologies Hosts Webinar on Adoption of Inpatient Basal/Bolus/Correction Subcutaneous Insulin Therapy

Monarch Medical Technologies today announced that the company will host a complimentary webinar, “Beyond Sliding Scale: Closing the Gap Between Current and Optimal Glycemic Management Practices” on February 13, from 1-2 p.m. EST.

January 30, 2018
·
2 min read
BioCapital

U.S. Patent Office Allows New CEL-SCI Patent For LEAPS Vaccine Platform Technology

CEL-SCI’s patented invention relates to methods for diagnosing, preventing, and treating disease by generating or modulating the immune response through the use of specific peptides.

January 30, 2018
·
5 min read
MedX Health Corp. Announces SIAscopy Order Exceeding $100,000 for Spain

MedX Health Corp. is pleased to announce that it received an initial order in excess of $100,000 for its pain-free, non-invasive skin assessment SIAscopy technology for use in Spain through its marketing partnership with OncoTech LLC.

January 30, 2018
·
3 min read
Business

Agilent Partners with Science Exchange

The partnership will promote access to Agilent-enabled services to the research community worldwide.

January 30, 2018
·
3 min read
Pharm Country

Cambrex Expands Process Research and Development Capabilities Across North America

The project forms part of the company’s strategic plan to increase its development capacity and resources in North America.

January 30, 2018
·
2 min read
Policy

EMA Grants Rexgenero’s Lead Product REX-001 Advanced Therapy Medicinal Product Certificate for Manufacturing Quality and Non-Clinical Data

The EMA certification paves the way for the MAA of its lead product REX-001, a novel cell therapy currently in a Phase III programme for the treatment of CLI.

January 30, 2018
·
1 min read
Business

Tyme Announces Prostate Cancer Collaboration With Dr. Mack Roach III of UCSF

As part of the deal, Tyme will provide support to Dr. Roach to conduct a randomized, investigator-sponsored trial comparing active surveillance to SM-88 maintenance therapy in patients prior to definitive therapy.

January 30, 2018
·
6 min read
Drug Development

Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase I/II Clinical Trial of FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

In its submission, Fibrocell reported the interim readout of safety data from three adult patients

January 30, 2018
·
6 min read
Genetown

PCI Synthesis Submits Patent for Synthesizing Azelaic Acid

Azelaic Acid is used for producing industrial products including polyesters, plasticizers and lubricants and is a component in skin-care products.

January 30, 2018
·
1 min read
Drug Development

First Patient Treated in Mapi Pharma’s Phase II Clinical Trial of GA Depot for Primary Progressive Multiple Sclerosis (PPMS)

This is a Phase II prospective, multicenter, single arm, open label study designed to assess the safety and efficacy of GA Depot in delaying the accumulation of disability in subjects with PPMS.

January 30, 2018
·
2 min read